Syndrome X: what's old, what's new, what's etiologic?
作者信息
Ginsberg H N
出版信息
J Clin Invest. 1993 Jul;92(1):3. doi: 10.1172/JCI116566.
Abstract
摘要
相似文献
1
Syndrome X: what's old, what's new, what's etiologic?
J Clin Invest. 1993 Jul;92(1):3. doi: 10.1172/JCI116566.
2
[Insulin resistance and arterial hypertension].
Invest Clin. 1992;33(1):1-3.
3
Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Panminerva Med. 2005 Dec;47(4):201-10.
4
Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation.
Circulation. 2005 Mar 22;111(11):1448-54. doi: 10.1161/01.CIR.0000158483.13093.9D.
5
[Risk factors and etiology of retinal vein occlusion].
Tunis Med. 1995 Feb;73(2):133-6.
6
Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus.
Diabetes Metab Rev. 1996 Apr;12(1):37-56. doi: 10.1002/(SICI)1099-0895(199603)12:1<37::AID-DMR154>3.0.CO;2-Q.
7
Metabolic syndrome' in a middle-aged Finnish population.
J Cardiovasc Risk. 1997 Aug;4(4):291-5.
8
9
Metabolic syndrome: what's in a name?
WMJ. 2006 Jul;105(5):17-20.
10
Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
Circulation. 2004 Nov 16;110(20):3259-69. doi: 10.1161/01.CIR.0000147614.85888.7A. Epub 2004 Nov 8.
引用本文的文献
1
Predictive Value of the Atherogenic Index of Plasma (AIP) for the Risk of Incident Ischemic Heart Disease among Non-Diabetic Koreans.
Nutrients. 2021 Sep 16;13(9):3231. doi: 10.3390/nu13093231.
本文引用的文献
1
Vascular disease and serum lipids in diabetes mellitus. Observations over thirty years (1931-1961).
Ann Intern Med. 1963 Feb;58:305-23. doi: 10.7326/0003-4819-58-2-305.
2
The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.
Lancet. 1963 Apr 13;1(7285):785-9. doi: 10.1016/s0140-6736(63)91500-9.
3
Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles.
J Clin Invest. 1993 Jul;92(1):141-6. doi: 10.1172/JCI116541.
4
Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography.
J Clin Invest. 1984 Oct;74(4):1515-25. doi: 10.1172/JCI111565.
5
Role of insulin in endogenous hypertriglyceridemia.
J Clin Invest. 1967 Nov;46(11):1756-67. doi: 10.1172/JCI105666.
6
Banting lecture 1988. Role of insulin resistance in human disease.
Diabetes. 1988 Dec;37(12):1595-607. doi: 10.2337/diab.37.12.1595.
7
Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.
J Clin Invest. 1990 Aug;86(2):379-84. doi: 10.1172/JCI114722.
8
Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B.
J Biol Chem. 1991 Mar 15;266(8):5080-6.
9
Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia.
J Clin Invest. 1975 Mar;55(3):454-61. doi: 10.1172/JCI107951.
Zotero 插件